A PhD in Chemical Engineering, Dr Anji Reddy set up Dr. Reddy’s Laboratories in 1984. Under his leadership, Dr. Reddy’s has become a synonym for innovative drug research and discovery in the Indian pharmaceutical industry. In 2001, it became the first non-Japanese Asian pharmaceutical company to be listed on the New York Stock Exchange. A recipient of several awards and honors – the Padmashri being one of them – Dr Anji Reddy is a member of the Prime Minister’s Council on Trade & Industry, as well as of various academic and industrial institutions worldwide.

An MS in Medicinal Chemistry, Satish Reddy has been the MD of Dr. Reddy’s since 1997. Under his stewardship, Dr. Reddy’s has become a world-renowned manufacturer of high value-added finished dosages, and continues its high-growth strategy by foraying into new markets / businesses. Anchoring the CSR initiative of Dr. Reddy’s, he mentors DRF in its interventions in the education and livelihoods sectors. Nominated as a ‘Young Global Leader’ by the World Economic Forum for 2007, he has been acknowledged globally for his innovative CSR concepts.

An active social worker, Anuradha Prasad takes keen interest in the activities of DRF, providing leadership for its various initiatives in the fields of education and livelihoods creation. She is also a Trustee of Jiddu Krishnamurti Trust, the Chairperson of the Hyderabad Chapter of ‘Society for Promotion of Indian Classical Music and Culture Amongst Youth’ (SPICMACAY), and an Advisory Board Member of ‘Centre for Social Initiative and Management’ (CSIM). She runs Saptaparni, an organization dedicated to promoting Indian performing arts, culture and heritage.